{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:10:09Z","timestamp":1740136209793,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1736-9","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T07:40:21Z","timestamp":1487576421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Changing the policy for intermittent preventive treatment with sulfadoxine\u2013pyrimethamine during pregnancy in Malawi"],"prefix":"10.1186","volume":"16","author":[{"given":"Chikondi A.","family":"Mwendera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Longwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamija","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Hongoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford M.","family":"Mutero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2875-8-85","volume":"8","author":"HA Williams","year":"2009","unstructured":"Williams HA, Vincent-Mark A, Herrera Y, Chang OJ. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar J. 2009;8:85.","journal-title":"Malar J."},{"key":"1736_CR2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/heapol\/czh051","volume":"19","author":"HA Williams","year":"2004","unstructured":"Williams HA, Durrheim D, Shretta R. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004;19:356\u201370.","journal-title":"Health Policy Plan."},{"key":"1736_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09581590310001615862","volume":"13","author":"DN Durrheim","year":"2003","unstructured":"Durrheim DN, Williams HA, Barnes K, Speare R, Sharp BL. Beyond evidence: a retrospective study of factors influencing a malaria treatment policy change in two South African provinces. Critical Public Health. 2003;13:309\u201330.","journal-title":"Critical Public Health."},{"key":"1736_CR4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/heapol\/czn024","volume":"23","author":"G Walt","year":"2008","unstructured":"Walt G, Shiffman J, Schneider H, Murray SF, Brugha R, Gilson L. \u2018Doing\u2019 health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan. 2008;23:308\u201317.","journal-title":"Health Policy Plan."},{"key":"1736_CR5","unstructured":"Anderson JE. Public policymaking. Cengage Learn. 2014."},{"key":"1736_CR6","volume-title":"A decade of progress in malaria policy and program development in Malawi: 1984\u20131993","author":"R Steketee","year":"1995","unstructured":"Steketee R. A decade of progress in malaria policy and program development in Malawi: 1984\u20131993. Washington, DC: United States Agency for International Development; 1995."},{"key":"1736_CR7","volume-title":"Five year implementation plan: 1985\u20131989","author":"Malawi National Malaria Control Programme","year":"1984","unstructured":"Malawi National Malaria Control Programme. Five year implementation plan: 1985\u20131989. Lilongwe: Ministry of Health; 1984."},{"key":"1736_CR8","volume-title":"Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine\u2013pyrimethamine (SP)","author":"WHO","year":"2012","unstructured":"WHO. Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine\u2013pyrimethamine (SP). Geneva: World Health Organization; 2012."},{"key":"1736_CR9","doi-asserted-by":"crossref","first-page":"e12012","DOI":"10.1371\/journal.pone.0012012","volume":"5","author":"G Feng","year":"2010","unstructured":"Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS ONE. 2010;5:e12012.","journal-title":"PLoS ONE"},{"key":"1736_CR10","first-page":"207","volume":"73","author":"LJ Schultz","year":"1995","unstructured":"Schultz LJ, Steketee RW, Chitsulo L, Wirima JJ. Antimalarials during pregnancy: a cost-effectiveness analysis. Bull World Health Organ. 1995;73:207\u201314.","journal-title":"Bull World Health Organ"},{"key":"1736_CR11","volume-title":"Antimalarial drug combination therapy: report of a WHO Technical Consultation","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Antimalarial drug combination therapy: report of a WHO Technical Consultation. Geneva: World Health Organization; 2001."},{"key":"1736_CR12","volume-title":"Revised guidelines for the treatment of malaria in Malawi","author":"Malawi National Malaria Control Programme","year":"2013","unstructured":"Malawi National Malaria Control Programme. Revised guidelines for the treatment of malaria in Malawi. Lilongwe: Ministry of Health; 2013."},{"key":"1736_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2875-4-51","volume":"4","author":"GM Mubyazi","year":"2005","unstructured":"Mubyazi GM, Gonzalez-Block MA. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine\u2013pyrimethamine as the first-line drug. Malar J. 2005;4:51.","journal-title":"Malar J."},{"key":"1736_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/505080","volume":"194","author":"SJ Filler","year":"2006","unstructured":"Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis. 2006;194:286\u201393.","journal-title":"J Infect Dis"},{"key":"1736_CR15","volume-title":"Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine\u2013pyrimethamine (IPTp-SP)","author":"WHO","year":"2013","unstructured":"WHO. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine\u2013pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2013."},{"key":"1736_CR16","first-page":"23","volume":"1","author":"A Giorgi","year":"1985","unstructured":"Giorgi A. Sketch of a psychological phenomenological method. Phenomenol Psychol Res. 1985;1:23\u201385.","journal-title":"Phenomenol Psychol Res"},{"key":"1736_CR17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00034983.1998.11813273","volume":"92","author":"F Verhoeff","year":"1998","unstructured":"Verhoeff F, Brabin B, Chimsuku L, Kazembe P, Russell W, Broadhead R. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol. 1998;92:141\u201350.","journal-title":"Ann Trop Med Parasitol"},{"key":"1736_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cis301","volume":"55","author":"SM Taylor","year":"2012","unstructured":"Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, et al. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012;55:42\u201350.","journal-title":"Clin Infect Dis"},{"key":"1736_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0035-9203(00)90083-X","volume":"94","author":"SJ Rogerson","year":"2000","unstructured":"Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997\u20131999. Trans R Soc Trop Med Hyg. 2000;94:549\u201353.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1736_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine\u2013pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309:594\u2013604.","journal-title":"JAMA"},{"key":"1736_CR21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4269\/ajtmh.2010.10-0264","volume":"83","author":"M Luntamo","year":"2010","unstructured":"Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K, Ashorn P. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg. 2010;83:1212\u201320.","journal-title":"Am J Trop Med Hyg"},{"key":"1736_CR22","doi-asserted-by":"crossref","first-page":"e41123","DOI":"10.1371\/journal.pone.0041123","volume":"7","author":"M Luntamo","year":"2012","unstructured":"Luntamo M, Rantala A, Meshnick SR, Cheung YB, Kulmala T, Maleta K, et al. The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS ONE. 2012;7:e41123.","journal-title":"PLoS ONE"},{"key":"1736_CR23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/tmi.12074","volume":"18","author":"M Luntamo","year":"2013","unstructured":"Luntamo M, Kulmala T, Cheung YB, Maleta K, Ashorn P. The effect of antenatal monthly sulphadoxine\u2013pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. Trop Med Int Health. 2013;18:386\u201397.","journal-title":"Trop Med Int Health"},{"key":"1736_CR24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/jit276","volume":"208","author":"J Gutman","year":"2013","unstructured":"Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis. 2013;208:907\u201316.","journal-title":"J Infect Dis."},{"key":"1736_CR25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.meegid.2011.11.006","volume":"12","author":"SM Taylor","year":"2012","unstructured":"Taylor SM, Antonia A, Feng G, Mwapasa V, Chaluluka E, Molyneux M, et al. Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Infect Genet Evol. 2012;12:282\u201390.","journal-title":"Infect Genet Evol"},{"key":"1736_CR26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/jiq072","volume":"203","author":"A Kapito-Tembo","year":"2011","unstructured":"Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine\u2013pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis. 2011;203:464\u201372.","journal-title":"J Infect Dis"},{"key":"1736_CR27","first-page":"8","volume":"14","author":"H Ashwood-Smith","year":"2002","unstructured":"Ashwood-Smith H, Coombes Y, Kaimila N, Bokosi M, Lungu K. Availability and use of sulphadoxine\u2013pyrimethamine (SP) in pregnancy in Blantyre District: a Safe Motherhood and BIMI Joint Survey. Malawi Med J. 2002;14:8\u201311.","journal-title":"Malawi Med J"},{"key":"1736_CR28","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2006","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006."},{"key":"1736_CR29","doi-asserted-by":"crossref","first-page":"e1002124","DOI":"10.1371\/journal.pmed.1002124","volume":"13","author":"M Madanitsa","year":"2016","unstructured":"Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, et al. Scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin\u2013piperaquine versus intermittent preventive therapy with sulfadoxine\u2013pyrimethamine for malaria in pregnancy in Malawi: an open-label randomized controlled trial. PLoS Med. 2016;13:e1002124.","journal-title":"PLoS Med."},{"key":"1736_CR30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","volume":"30","author":"PJ Peters","year":"2007","unstructured":"Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine\/pyrimethamine. Drug Saf. 2007;30:481\u2013501.","journal-title":"Drug Saf"},{"key":"1736_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-015-0072-1","volume":"14","author":"C Mwendera","year":"2016","unstructured":"Mwendera C, de Jager C, Longwe H, Phiri K, Hongoro C, Mutero CM. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study. Health Res Pol Syst. 2016;14:1.","journal-title":"Health Res Pol Syst"},{"key":"1736_CR32","volume-title":"Malaria in pregnancy working group: 18th annual meeting, Nairobi","author":"RB Malaria","year":"2016","unstructured":"Malaria RB. Malaria in pregnancy working group: 18th annual meeting, Nairobi. Kenya: World Health Organization; 2016."},{"key":"1736_CR33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12936-016-1547-4","volume":"15","author":"CA Mwendera","year":"2016","unstructured":"Mwendera CA, Jager C, Longwe H, Phiri K, Hongoro C, Mutero CM. Facilitating factors and barriers to malaria research utilization for policy development in Malawi. Malar J. 2016;15:512.","journal-title":"Malar J."},{"key":"1736_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1505-3-11","volume":"3","author":"JS Martins","year":"2009","unstructured":"Martins JS, Zwi AB, Martins N, Kelly PM. Malaria control in Timor-Leste during a period of political instability: what lessons can be learned? Conflict Health. 2009;3:1.","journal-title":"Conflict Health."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:56:26Z","timestamp":1498373786000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1736-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"article-number":"84"}}